Nutraceuticals: Scaling Without Breaking Supply

Nutraceuticals are growing faster than almost any adjacent health category, but the infrastructure behind them hasn't caught up. Tariff volatility and raw material shortages are exposing single-source dependencies in botanical and specialty ingredient supply. Regulators in the US and EU are simultaneously tightening scrutiny — from GRAS reform and marketing enforcement to new packaging and traceability rules. And consumers are no longer satisfied with wellness claims; they want proof of bioavailability and efficacy.

This panel examines how nutraceutical companies are adopting pharma-grade discipline — supplier qualification, traceability, evidence-based formulation — without losing the speed that defines the category. Topics include diversifying ingredient sourcing under tariff pressure, navigating a fragmenting regulatory landscape, and what "proof" will mean for the next generation of functional health products.